ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date

Sunday, November 10, 2019

9:00AM-11:00AM
Abstract Number: 694
Body Mass Index at Time of Diagnosis Is Predictive of Future Disease Activity in SLE
SLE – Clinical Poster I: Epidemiology & Pathogenesis
9:00AM-11:00AM
Abstract Number: 273
Bone Health in Lupus: Findings from the Southern California Lupus Registry
Health Services Research Poster I – ACR/ARP
9:00AM-11:00AM
Abstract Number: 364
Calcium Pyrophosphate Crystal Arthritis During Hospitalizations: A Prospective, Crystal-Proven Case Series
Metabolic & Crystal Arthropathies Poster I: Clinical
9:00AM-11:00AM
Abstract Number: 483
Can a Single Question on Functional Impairments Facilitate the Diagnosis of Early Inflammatory Arthritis? A Cross-Sectional Derivation and Validation Study in Two Early Arthritis Recognition Clinics
RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis
9:00AM-11:00AM
Abstract Number: 613
Can Fecal Calprotectin Predict Future Development of Inflammatory Bowel Disease in Axial Spondyloarthritis Patients? – TReasure Real-Life Preliminary Data
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features
9:00AM-11:00AM
Abstract Number: 790
Can High ANA Titre Combined with Clinical Features Predict Developing Autoimmune Conditions in Children?
Pediatric Rheumatology – ePoster I: Basic Science, Biomarkers, & Sclerodermic Fever
9:00AM-11:00AM
Abstract Number: 283
Can Synovial Hypertrophy in the Feet Without Doppler Change During Treatment – Results from a Longitudinal Study of Rheumatoid Arthritis Patients Initiating Biological DMARD
Imaging Of Rheumatic Diseases Poster I
9:00AM-11:00AM
Abstract Number: 802
Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial
Pediatric Rheumatology – ePoster I: Basic Science, Biomarkers, & Sclerodermic Fever
9:00AM-11:00AM
Abstract Number: 745
Cardiac Involvements Are Related to Poor Prognosis in Patients with Takayasu’s Arteritis in China
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica
9:00AM-11:00AM
Abstract Number: 326
Cardiac Sarcoidosis Awareness: Are We Underdiagnosing?
Measures Of Healthcare Quality Poster I: Testing, Screening, & Treating
9:00AM-11:00AM
Abstract Number: 349
Carotid Atherosclerosis and Sonographic Signs of Urate Crystal Deposits in Patients with Gout: An Association Study
Metabolic & Crystal Arthropathies Poster I: Clinical
9:00AM-11:00AM
Abstract Number: 687
CCP Autoantibody Positive SLE Patients Show Unique Enrichments in SLE Criteria and Autoantibody Biomarkers That Vary by Race
SLE – Clinical Poster I: Epidemiology & Pathogenesis
9:00AM-11:00AM
Abstract Number: 101
CD126 Negative CD4+Foxp3+ Cell Represents a Superior Treg Subset in Treating Autoimmune Diseases
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster
9:00AM-11:00AM
Abstract Number: 65
CD6 Modulation Ameliorates Skin and Kidney Disease in a Spontaneous Murine Model of SLE
SLE – Animal Models Poster
9:00AM-11:00AM
Abstract Number: 115
CD8+ Cytotoxic T Lymphocytes Are Clonally-expanded in IgG4-related Disease and Home to Affected Tissues
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster
  • «Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 65
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology